AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients – Reuters.com June 4, 2023
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial – AstraZeneca May 17, 2023